Eric R. Olson

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Todd Rosenthal, as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Eric R. Olson:

Company Role Class Num Shares Value Price $ Report Date Ownership
Syros Pharmaceuticals, Inc. Chief Scientific Officer Common Stock 6,661 $29,442 $4.42 17 Jul 2023 Direct

Insider Reports Filed by Eric R. Olson

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SYRS Syros Pharmaceuticals, Inc. 17 Jul 2023 1 -$2,412 4 Chief Scientific Officer 18 Jul 2023, 20:27
SYRS Syros Pharmaceuticals, Inc. 31 Mar 2023 3 -$1,607 4 Chief Scientific Officer 04 Apr 2023, 18:54
SYRS Syros Pharmaceuticals, Inc. 16 Feb 2023 1 $0 4 Chief Scientific Officer 21 Feb 2023, 15:23
SYRS Syros Pharmaceuticals, Inc. 06 Oct 2022 2 $0 4 Chief Scientific Officer 11 Oct 2022, 16:38
SYRS Syros Pharmaceuticals, Inc. 01 Apr 2022 1 -$30,538 4 Chief Scientific Officer 04 Apr 2022, 17:02
SYRS Syros Pharmaceuticals, Inc. 15 Feb 2022 3 $0 4 Chief Scientific Officer 17 Feb 2022, 15:08
SYRS Syros Pharmaceuticals, Inc. 05 Jan 2022 1 -$7,655 4 Chief Scientific Officer 06 Jan 2022, 16:02
SYRS Syros Pharmaceuticals, Inc. 01 Jul 2021 1 -$6,460 4 Chief Scientific Officer 01 Jul 2021, 17:20